Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| CLOROX CO /DE/CLX · Entity 3474 | SVP-Chief Product Supply | November 04, 2020 | November 06, 2020 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
CLOROX CO /DE/
Report date November 04, 2020 · Filed November 06, 2020
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 15,300 |
Ending reported balance
After 2020-11-04 transaction · row 4
4 source rows · reconciled sequenceRow 1 · 2020-11-04 · Exercise / conversion · Acquired 16,930 · Balance 30,115 Row 2 · 2020-11-04 · Exercise / conversion · Acquired 12,360 · Balance 42,475 Row 3 · 2020-11-04 · Sale · Disposed 5,740 · Balance 36,735 F1: This transaction was executed in multiple trades at prices ranging from $213.97 to $214.46. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Row 4 · 2020-11-04 · Sale · Disposed 21,435 · Balance 15,300 F2: This transaction was executed in multiple trades at prices ranging from $212.96 to $213.94. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. |
| Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $111.60 · Expires 2025-09-15 | Direct | 0 |
Reported balance
After 2020-11-04 transaction · row 5
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 5 · 2020-11-04 · Exercise / conversion · Disposed 12,360 · Balance 0 |
| Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $89.82 · Expires 2024-09-17 | Direct | 0 |
Reported balance
After 2020-11-04 transaction · row 6
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 6 · 2020-11-04 · Exercise / conversion · Disposed 16,930 · Balance 0 |
Filing footnotes · ownership attribution and instrument terms
F1: This transaction was executed in multiple trades at prices ranging from $213.97 to $214.46. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
F2: This transaction was executed in multiple trades at prices ranging from $212.96 to $213.94. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| November 04, 2020 Filed Nov 6, 2020 23:31 UTC | CLOROX CO /DE/ CLX · Entity 3474 | Exercise / conversionStock Option (Right to Buy) · Derivative | 16,930 | $0.00 Strike: $89.82 | $0.00 |
DisclosureSEC source: 0001225208-20-013209 · doc4.xml · derivative · entry 6 Mowery Andrew J · CIK 0001724466 · SVP-Chief Product Supply 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 16,930 shares Expires 2024-09-17 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 04, 2020 Filed Nov 6, 2020 23:31 UTC | CLOROX CO /DE/ CLX · Entity 3474 | Exercise / conversionStock Option (Right to Buy) · Derivative | 12,360 | $0.00 Strike: $111.60 | $0.00 |
DisclosureSEC source: 0001225208-20-013209 · doc4.xml · derivative · entry 5 Mowery Andrew J · CIK 0001724466 · SVP-Chief Product Supply 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 12,360 shares Expires 2025-09-15 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 04, 2020 Filed Nov 6, 2020 23:31 UTC | CLOROX CO /DE/ CLX · Entity 3474 | SaleCommon Stock | 21,435 | $213.37 | $4,573,667.40 |
DisclosureSEC source: 0001225208-20-013209 · doc4.xml · nonDerivative · entry 4 Mowery Andrew J · CIK 0001724466 · SVP-Chief Product Supply 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,300 F2 · price: This transaction was executed in multiple trades at prices ranging from $212.96 to $213.94. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| November 04, 2020 Filed Nov 6, 2020 23:31 UTC | CLOROX CO /DE/ CLX · Entity 3474 | SaleCommon Stock | 5,740 | $214.07 | $1,228,737.12 |
DisclosureSEC source: 0001225208-20-013209 · doc4.xml · nonDerivative · entry 3 Mowery Andrew J · CIK 0001724466 · SVP-Chief Product Supply 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 36,735 F1 · price: This transaction was executed in multiple trades at prices ranging from $213.97 to $214.46. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| November 04, 2020 Filed Nov 6, 2020 23:31 UTC | CLOROX CO /DE/ CLX · Entity 3474 | Exercise / conversionCommon Stock | 12,360 | $111.60 | $1,379,376.00 |
DisclosureSEC source: 0001225208-20-013209 · doc4.xml · nonDerivative · entry 2 Mowery Andrew J · CIK 0001724466 · SVP-Chief Product Supply 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 42,475 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 04, 2020 Filed Nov 6, 2020 23:31 UTC | CLOROX CO /DE/ CLX · Entity 3474 | Exercise / conversionCommon Stock | 16,930 | $89.82 | $1,520,652.60 |
DisclosureSEC source: 0001225208-20-013209 · doc4.xml · nonDerivative · entry 1 Mowery Andrew J · CIK 0001724466 · SVP-Chief Product Supply 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,115 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 22, 2020 Filed Sep 24, 2020 20:29 UTC | CLOROX CO /DE/ CLX · Entity 3474 | GrantStock Option (Right to Buy) · Derivative | 4,524 | $0.00 Strike: $212.38 | $0.00 |
DisclosureSEC source: 0001225208-20-011794 · doc4.xml · derivative · entry 2 Mowery Andrew J · CIK 0001724466 · SVP-Chief Product Supply 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,524 Underlying: Common Stock · 4,524 shares Expires 2030-09-22 F3 · kind: Option vests in 4 equal installments - 1/4 on each of the first, second, third and fourth anniversaries of the grant date. F3 · derivative.exercise_date: Option vests in 4 equal installments - 1/4 on each of the first, second, third and fourth anniversaries of the grant date. Read SEC document |
| September 22, 2020 Filed Sep 24, 2020 20:29 UTC | CLOROX CO /DE/ CLX · Entity 3474 | GrantCommon Stock | 659 | $212.38 | $139,958.42 |
DisclosureSEC source: 0001225208-20-011794 · doc4.xml · nonDerivative · entry 1 Mowery Andrew J · CIK 0001724466 · SVP-Chief Product Supply 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,185 F1 · kind: The Restricted Stock Units will vest in 4 equal installments - 1/4 on each of the first, second, third and fourth anniversaries of the grant date. F2 · balance_after: Includes 43 shares acquired pursuant to a dividend reinvestment feature of the Company's Stock Incentive Plan. Read SEC document |
| August 20, 2020 Filed Aug 24, 2020 23:25 UTC | CLOROX CO /DE/ CLX · Entity 3474 | Tax withholdingCommon Stock | 699 | $228.30 | $159,581.70 |
DisclosureSEC source: 0001225208-20-010960 · doc4.xml · nonDerivative · entry 2 Mowery Andrew J · CIK 0001724466 · SVP-Chief Product Supply 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,483 F2 · kind: Withholding of stock to pay tax liability under the Company's Stock Withholding Arrangement. Read SEC document |
| August 20, 2020 Filed Aug 24, 2020 23:25 UTC | CLOROX CO /DE/ CLX · Entity 3474 | GrantCommon Stock | 1,548 | $228.30 | $353,408.40 |
DisclosureSEC source: 0001225208-20-010960 · doc4.xml · nonDerivative · entry 1 Mowery Andrew J · CIK 0001724466 · SVP-Chief Product Supply 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,182 F1 · kind: Settlement of 2017 Performance Unit Grant that vested 8/20/2020. Read SEC document |
| August 06, 2020 Filed Aug 10, 2020 21:42 UTC | CLOROX CO /DE/ CLX · Entity 3474 | Exercise / conversionStock Option (Right to Buy) · Derivative | 6,110 | $0.00 Strike: $84.45 | $0.00 |
DisclosureSEC source: 0001225208-20-010463 · doc4.xml · derivative · entry 7 Mowery Andrew J · CIK 0001724466 · SVP-Chief Product Supply 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 6,110 shares Expires 2023-09-17 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 06, 2020 Filed Aug 10, 2020 21:42 UTC | CLOROX CO /DE/ CLX · Entity 3474 | Exercise / conversionStock Option (Right to Buy) · Derivative | 8,120 | $0.00 Strike: $72.11 | $0.00 |
DisclosureSEC source: 0001225208-20-010463 · doc4.xml · derivative · entry 6 Mowery Andrew J · CIK 0001724466 · SVP-Chief Product Supply 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 8,120 shares Expires 2022-09-11 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 06, 2020 Filed Aug 10, 2020 21:42 UTC | CLOROX CO /DE/ CLX · Entity 3474 | SaleCommon Stock | 5,775 | $235.27 | $1,358,702.73 |
DisclosureSEC source: 0001225208-20-010463 · doc4.xml · nonDerivative · entry 5 Mowery Andrew J · CIK 0001724466 · SVP-Chief Product Supply 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,634 F3 · price: This transaction was executed in multiple trades at prices ranging from $234.64 to $235.64. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. F4 · balance_after: Includes 64 shares acquired pursuant to a dividend reinvestment feature of the Company's Stock Incentive Plan. Read SEC document |
| August 06, 2020 Filed Aug 10, 2020 21:42 UTC | CLOROX CO /DE/ CLX · Entity 3474 | SaleCommon Stock | 3,682 | $236.16 | $869,549.22 |
DisclosureSEC source: 0001225208-20-010463 · doc4.xml · nonDerivative · entry 4 Mowery Andrew J · CIK 0001724466 · SVP-Chief Product Supply 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,409 F2 · price: This transaction was executed in multiple trades at prices ranging from $235.69 to $236.68. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| August 06, 2020 Filed Aug 10, 2020 21:42 UTC | CLOROX CO /DE/ CLX · Entity 3474 | SaleCommon Stock | 3,475 | $236.91 | $823,252.87 |
DisclosureSEC source: 0001225208-20-010463 · doc4.xml · nonDerivative · entry 3 Mowery Andrew J · CIK 0001724466 · SVP-Chief Product Supply 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,091 F1 · price: This transaction was executed in multiple trades at prices ranging from $236.74 to $237.24. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| August 06, 2020 Filed Aug 10, 2020 21:42 UTC | CLOROX CO /DE/ CLX · Entity 3474 | Exercise / conversionCommon Stock | 6,110 | $84.45 | $515,989.50 |
DisclosureSEC source: 0001225208-20-010463 · doc4.xml · nonDerivative · entry 2 Mowery Andrew J · CIK 0001724466 · SVP-Chief Product Supply 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,566 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 06, 2020 Filed Aug 10, 2020 21:42 UTC | CLOROX CO /DE/ CLX · Entity 3474 | Exercise / conversionCommon Stock | 8,120 | $72.11 | $585,533.20 |
DisclosureSEC source: 0001225208-20-010463 · doc4.xml · nonDerivative · entry 1 Mowery Andrew J · CIK 0001724466 · SVP-Chief Product Supply 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,456 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 04, 2019 Filed Nov 6, 2019 21:29 UTC | CLOROX CO /DE/ CLX · Entity 3474 | Exercise / conversionStock Option (Right to Buy) · Derivative | 6,100 | $0.00 Strike: $68.15 | $0.00 |
DisclosureSEC source: 0001225208-19-014198 · doc4.xml · derivative · entry 3 Mowery Andrew J · CIK 0001724466 · SVP-Chief Product Supply 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 6,100 shares Expires 2021-09-13 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 04, 2019 Filed Nov 6, 2019 21:29 UTC | CLOROX CO /DE/ CLX · Entity 3474 | SaleCommon Stock | 5,648 | $146.29 | $826,219.94 |
DisclosureSEC source: 0001225208-19-014198 · doc4.xml · nonDerivative · entry 2 Mowery Andrew J · CIK 0001724466 · SVP-Chief Product Supply 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,272 F1 · price: This transaction was executed in multiple trades at prices ranging from $146.281 to $146.305. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| November 04, 2019 Filed Nov 6, 2019 21:29 UTC | CLOROX CO /DE/ CLX · Entity 3474 | Exercise / conversionCommon Stock | 6,100 | $68.15 | $415,715.00 |
DisclosureSEC source: 0001225208-19-014198 · doc4.xml · nonDerivative · entry 1 Mowery Andrew J · CIK 0001724466 · SVP-Chief Product Supply 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,920 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 17, 2019 Filed Sep 19, 2019 23:37 UTC | CLOROX CO /DE/ CLX · Entity 3474 | GrantStock Option (Right to Buy) · Derivative | 17,484 | $0.00 Strike: $155.54 | $0.00 |
DisclosureSEC source: 0001225208-19-012722 · doc4.xml · derivative · entry 1 Mowery Andrew J · CIK 0001724466 · SVP-Chief Product Supply 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,484 Underlying: Common Stock · 17,484 shares Expires 2029-09-17 F1 · kind: Option vests in 4 equal installments - 1/4 on each of the first, second, third and fourth anniversaries of the grant date. F1 · derivative.exercise_date: Option vests in 4 equal installments - 1/4 on each of the first, second, third and fourth anniversaries of the grant date. Read SEC document |
| August 22, 2019 Filed Aug 26, 2019 21:58 UTC | CLOROX CO /DE/ CLX · Entity 3474 | Tax withholdingCommon Stock | 417 | $159.15 | $66,365.55 |
DisclosureSEC source: 0001225208-19-011889 · doc4.xml · nonDerivative · entry 3 Mowery Andrew J · CIK 0001724466 · SVP-Chief Product Supply 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,820 Read SEC document |
| August 22, 2019 Filed Aug 26, 2019 21:58 UTC | CLOROX CO /DE/ CLX · Entity 3474 | GrantCommon Stock | 1,372 | $159.15 | $218,353.80 |
DisclosureSEC source: 0001225208-19-011889 · doc4.xml · nonDerivative · entry 2 Mowery Andrew J · CIK 0001724466 · SVP-Chief Product Supply 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,237 F2 · kind: Settlement of 2016 Performance Unit Grant that vested 8/22/2019. Read SEC document |
| August 07, 2019 Filed Aug 26, 2019 21:58 UTC | CLOROX CO /DE/ CLX · Entity 3474 | GiftCommon Stock | 130 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-19-011889 · doc4.xml · nonDerivative · entry 1 Mowery Andrew J · CIK 0001724466 · SVP-Chief Product Supply 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,865 F1 · kind: Shares transferred as a bona fide gift without any consideration. Read SEC document |
| March 01, 2019 Filed Mar 5, 2019 21:28 UTC | CLOROX CO /DE/ CLX · Entity 3474 | Exercise / conversionStock Option (Right to Buy) · Derivative | 6,990 | $0.00 Strike: $66.48 | $0.00 |
DisclosureSEC source: 0001225208-19-004590 · doc4.xml · derivative · entry 3 Mowery Andrew J · CIK 0001724466 · SVP-Chief Product Supply 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 6,990 shares Expires 2020-09-14 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 01, 2019 Filed Mar 5, 2019 21:28 UTC | CLOROX CO /DE/ CLX · Entity 3474 | SaleCommon Stock | 5,340 | $156.44 | $835,372.51 |
DisclosureSEC source: 0001225208-19-004590 · doc4.xml · nonDerivative · entry 2 Mowery Andrew J · CIK 0001724466 · SVP-Chief Product Supply 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,995 F1 · price: This transaction was executed in multiple trades at prices ranging from $156.25 to $156.57. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. F2 · balance_after: Includes 103 shares acquired pursuant to a dividend reinvestment feature of the Company's Stock Incentive Plan. Read SEC document |
| March 01, 2019 Filed Mar 5, 2019 21:28 UTC | CLOROX CO /DE/ CLX · Entity 3474 | Exercise / conversionCommon Stock | 6,990 | $66.48 | $464,695.20 |
DisclosureSEC source: 0001225208-19-004590 · doc4.xml · nonDerivative · entry 1 Mowery Andrew J · CIK 0001724466 · SVP-Chief Product Supply 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,335 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 18, 2018 Filed Sep 20, 2018 22:05 UTC | CLOROX CO /DE/ CLX · Entity 3474 | GrantStock Option (Right to Buy) · Derivative | 12,320 | $0.00 Strike: $151.85 | $0.00 |
DisclosureSEC source: 0001225208-18-013647 · doc4.xml · derivative · entry 1 Mowery Andrew J · CIK 0001724466 · SVP-Chief Product Supply 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,320 Underlying: Common Stock · 12,320 shares Expires 2028-09-18 F1 · kind: Option vests in 4 equal installments - 1/4 on each of the first, second, third and fourth anniversaries of the grant date. F1 · derivative.exercise_date: Option vests in 4 equal installments - 1/4 on each of the first, second, third and fourth anniversaries of the grant date. Read SEC document |
| August 17, 2018 Filed Aug 21, 2018 22:14 UTC | CLOROX CO /DE/ CLX · Entity 3474 | Exercise / conversionStock Option (Right to Buy) · Derivative | 6,270 | $0.00 Strike: $57.25 | $0.00 |
DisclosureSEC source: 0001225208-18-012816 · doc4.xml · derivative · entry 3 Mowery Andrew J · CIK 0001724466 · SVP-Chief Product Supply 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 6,270 shares Expires 2019-09-15 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 17, 2018 Filed Aug 21, 2018 22:14 UTC | CLOROX CO /DE/ CLX · Entity 3474 | Tax withholdingCommon Stock | 3,599 | $147.53 | $530,960.47 |
DisclosureSEC source: 0001225208-18-012816 · doc4.xml · nonDerivative · entry 2 Mowery Andrew J · CIK 0001724466 · SVP-Chief Product Supply 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,242 Read SEC document |
| August 17, 2018 Filed Aug 21, 2018 22:14 UTC | CLOROX CO /DE/ CLX · Entity 3474 | Exercise / conversionCommon Stock | 6,270 | $57.25 | $358,957.50 |
DisclosureSEC source: 0001225208-18-012816 · doc4.xml · nonDerivative · entry 1 Mowery Andrew J · CIK 0001724466 · SVP-Chief Product Supply 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,841 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 16, 2018 Filed Aug 20, 2018 22:51 UTC | CLOROX CO /DE/ CLX · Entity 3474 | Tax withholdingCommon Stock | 666 | $146.77 | $97,748.82 |
DisclosureSEC source: 0001225208-18-012774 · doc4.xml · nonDerivative · entry 2 Mowery Andrew J · CIK 0001724466 · SVP-Chief Product Supply 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,571 F2 · kind: Withholding of stock to pay tax liability under the Company's Stock Withholding Arrangement. Read SEC document |
| August 16, 2018 Filed Aug 20, 2018 22:51 UTC | CLOROX CO /DE/ CLX · Entity 3474 | GrantCommon Stock | 2,190 | $146.77 | $321,426.30 |
DisclosureSEC source: 0001225208-18-012774 · doc4.xml · nonDerivative · entry 1 Mowery Andrew J · CIK 0001724466 · SVP-Chief Product Supply 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,237 F1 · kind: Settlement of 2015 Performance Unit Grant that vested 8/16/2018. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.